Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Racotumomab in Advanced NSCLC
NCT01240447Phase 2Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Start
- Sep 2009
- Primary completion
- Aug 2012
- Modality
- Monoclonal Antibodies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of racotumomab in non-small cell lung cancer (NSCLC), sponsored by Laboratorio Elea Phoenix S.A.. Started Sep 2009; status: completed.
02
Drugs
racotumomab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01240447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240447.